Moreover, after miR-155-5p is transferred to colon cancer cells through M2 MDEs, it targets ZC3H12B and negatively regulates the stability of IL-6 mRNA, increases IL-6 release by tumor cells, and suppresses T-cell immune responses, promoting immune escape in colon cancer (120). Here, IL6 is linked to neoplasm.